Yahoo
Brussels - Delayed Quote EUR

Azelis Group NV (AZE.BR)

12.00 -0.31 (-2.52%)
At close: 5:35:15 PM GMT+2
Chart Range Bar
Loading chart for AZE.BR
  • Previous Close 12.31
  • Open 12.28
  • Bid --
  • Ask --
  • Day's Range 11.87 - 12.28
  • 52 Week Range 6.88 - 12.68
  • Volume 156,293
  • Avg. Volume 277,604
  • Market Cap (intraday) 2.921B
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) 25.53
  • EPS (TTM) 0.47
  • Earnings Date Jul 30, 2026
  • Forward Dividend & Yield 0.23 (1.84%)
  • Ex-Dividend Date Jun 29, 2026
  • 1y Target Est 13.73

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

www.azelis.com

3,998

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 9/7/2026, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .

YTD Return

AZE.BR
30.92%
BEL 20 (^BFX)
14.24%

1-Year Return

AZE.BR
2.15%
BEL 20 (^BFX)
21.64%

3-Year Return

AZE.BR
32.22%
BEL 20 (^BFX)
59.13%

5-Year Return

AZE.BR
54.13%
BEL 20 (^BFX)
35.08%

Analyst Insights

View More

Analyst Price Targets

10.00 Low
13.73 Average
12.00 Current
16.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.74%

  • Return on Assets (ttm)

    3.55%

  • Return on Equity (ttm)

    4.12%

  • Revenue (ttm)

    4.12B

  • Net Income Avi to Common (ttm)

    112.8M

  • Diluted EPS (ttm)

    0.47

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    245.31M

  • Total Debt/Equity (mrq)

    64.71%

  • Levered Free Cash Flow (ttm)

    224.37M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: